Muse Cells: Ushering in a New Era of Stem Cell-based Therapy for Stroke

Overview

Journal Stem Cell Res Ther

Publisher Biomed Central

Date 2022 Aug 19

PMID 35986359

Authors

Han Li

Jinghui Wei

Xuejia Liu

Ping Zhang

Juntang Lin

Affiliations

Soon will be listed here.

Abstract

Stem cell-based regenerative therapies have recently become promising and advanced for treating stroke. Mesenchymal stem cells (MSCs) and induced pluripotent stem cells (iPSCs) have received the most attention for treating stroke because of the outstanding paracrine function of MSCs and the three-germ-layer differentiation ability of iPSCs. However, the unsatisfactory homing ability, differentiation, integration, and survival time in vivo limit the effectiveness of MSCs in regenerative medicine. The inherent tumorigenic property of iPSCs renders complete differentiation necessary before transplantation, which is complicated and expensive and affects the consistency among cell batches. Multilineage differentiating stress-enduring (Muse) cells are natural pluripotent stem cells in the connective tissues of nearly every organ and thus are considered nontumorigenic. A single Muse cell can differentiate into all three-germ-layer, preferentially migrate to damaged sites after transplantation, survive in hostile environments, and spontaneously differentiate into tissue-compatible cells, all of which can compensate for the shortcomings of MSCs and iPSCs. This review summarizes the recent progress in understanding the biological properties of Muse cells and highlights the differences between Muse cells and other types of stem cells. Finally, we summarized the current research progress on the application of Muse cells on stroke and challenges from bench to bedside.

Citing Articles

Sources and applications of endothelial seed cells: a review.

Deng D, Zhang Y, Tang B, Zhang Z Stem Cell Res Ther. 2024; 15(1):175.

PMID: 38886767 PMC: 11184868. DOI: 10.1186/s13287-024-03773-6.

Multilineage-differentiating stress-enduring cells: a powerful tool for tissue damage repair.

Que H, Mai E, Hu Y, Li H, Zheng W, Jiang Y Front Cell Dev Biol. 2024; 12:1380785.

PMID: 38872932 PMC: 11169632. DOI: 10.3389/fcell.2024.1380785.

Biological characteristics of Muse cells derived from MenSCs and their application in acute liver injury and intracerebral hemorrhage diseases.

Li H, Wei J, Li M, Li Y, Zhang T, Tian J Regen Ther. 2024; 27:48-62.

PMID: 38496012 PMC: 10940801. DOI: 10.1016/j.reth.2024.03.003.

Multilineage Differentiating Stress Enduring (Muse) Cells: A New Era of Stem Cell-Based Therapy.

Alanazi R, Alhwity B, Almahlawi R, Alatawi B, Albalawi S, Albalawi R Cells. 2023; 12(13).

PMID: 37443710 PMC: 10340735. DOI: 10.3390/cells12131676.

Deep learning models for cancer stem cell detection: a brief review.

Chen J, Xu L, Li X, Park S Front Immunol. 2023; 14:1214425.

PMID: 37441078 PMC: 10333688. DOI: 10.3389/fimmu.2023.1214425.

References

Chen Q, Shou P, Zheng C, Jiang M, Cao G, Yang Q . Fate decision of mesenchymal stem cells: adipocytes or osteoblasts?. Cell Death Differ. 2016; 23(7):1128-39. PMC: 4946886. DOI: 10.1038/cdd.2015.168. View

Aizman I, Tate C, McGrogan M, Case C . Extracellular matrix produced by bone marrow stromal cells and by their derivative, SB623 cells, supports neural cell growth. J Neurosci Res. 2009; 87(14):3198-206. DOI: 10.1002/jnr.22146. View

Hori E, Hayakawa Y, Hayashi T, Hori S, Okamoto S, Shibata T . Mobilization of Pluripotent Multilineage-Differentiating Stress-Enduring Cells in Ischemic Stroke. J Stroke Cerebrovasc Dis. 2016; 25(6):1473-81. DOI: 10.1016/j.jstrokecerebrovasdis.2015.12.033. View

Guo Y, Xue Y, Wang P, Cui Z, Cao J, Liu S . Muse cell spheroids have therapeutic effect on corneal scarring wound in mice and tree shrews. Sci Transl Med. 2020; 12(562). DOI: 10.1126/scitranslmed.aaw1120. View

Huang J, Wang F, Okuka M, Liu N, Ji G, Ye X . Association of telomere length with authentic pluripotency of ES/iPS cells. Cell Res. 2011; 21(5):779-92. PMC: 3203670. DOI: 10.1038/cr.2011.16. View

Visweswaran M, Pohl S, Arfuso F, Newsholme P, Dilley R, Pervaiz S . Multi-lineage differentiation of mesenchymal stem cells - To Wnt, or not Wnt. Int J Biochem Cell Biol. 2015; 68:139-47. DOI: 10.1016/j.biocel.2015.09.008. View

Abe T, Aburakawa D, Niizuma K, Iwabuchi N, Kajitani T, Wakao S . Intravenously Transplanted Human Multilineage-Differentiating Stress-Enduring Cells Afford Brain Repair in a Mouse Lacunar Stroke Model. Stroke. 2019; 51(2):601-611. DOI: 10.1161/STROKEAHA.119.026589. View

Nelson P, Kondziolka D, Wechsler L, Goldstein S, Gebel J, Decesare S . Clonal human (hNT) neuron grafts for stroke therapy: neuropathology in a patient 27 months after implantation. Am J Pathol. 2002; 160(4):1201-6. PMC: 1867232. DOI: 10.1016/S0002-9440(10)62546-1. View

Yin X, Wang C, Du P, Wang X, Lu Y, Sun Y . Muse cells decrease the neuroinflammatory response by modulating the proportion of M1 and M2 microglia . Neural Regen Res. 2022; 18(1):213-218. PMC: 9241390. DOI: 10.4103/. View

10.

Kushida Y, Wakao S, Dezawa M . Muse Cells Are Endogenous Reparative Stem Cells. Adv Exp Med Biol. 2018; 1103:43-68. DOI: 10.1007/978-4-431-56847-6_3. View

11.

Gardino A, Yaffe M . 14-3-3 proteins as signaling integration points for cell cycle control and apoptosis. Semin Cell Dev Biol. 2011; 22(7):688-95. PMC: 3507455. DOI: 10.1016/j.semcdb.2011.09.008. View

12.

Sharma A, Sane H, Gokulchandran N, Khopkar D, Paranjape A, Sundaram J . Autologous bone marrow mononuclear cells intrathecal transplantation in chronic stroke. Stroke Res Treat. 2014; 2014:234095. PMC: 4121152. DOI: 10.1155/2014/234095. View

13.

Kajitani T, Endo T, Iwabuchi N, Inoue T, Takahashi Y, Abe T . Association of intravenous administration of human Muse cells with deficit amelioration in a rat model of spinal cord injury. J Neurosurg Spine. 2021; 34(4):648-655. DOI: 10.3171/2020.7.SPINE20293. View

14.

Shimamura N, Kakuta K, Wang L, Naraoka M, Uchida H, Wakao S . Neuro-regeneration therapy using human Muse cells is highly effective in a mouse intracerebral hemorrhage model. Exp Brain Res. 2016; 235(2):565-572. DOI: 10.1007/s00221-016-4818-y. View

15.

Xie F, Zhao Y, Wang S, Ma J, Wang X, Qian L . Identification, characterization, and functional investigation of circular RNAs in subventricular zone of adult rat brain. J Cell Biochem. 2018; 120(3):3428-3437. DOI: 10.1002/jcb.27614. View

16.

Bhasin A, Srivastava M, Bhatia R, Mohanty S, Kumaran S, Bose S . Autologous intravenous mononuclear stem cell therapy in chronic ischemic stroke. J Stem Cells Regen Med. 2014; 8(3):181-9. PMC: 3908296. View

17.

Petit I, Jin D, Rafii S . The SDF-1-CXCR4 signaling pathway: a molecular hub modulating neo-angiogenesis. Trends Immunol. 2007; 28(7):299-307. PMC: 2952492. DOI: 10.1016/j.it.2007.05.007. View

18.

Leng Z, Sun D, Huang Z, Tadmori I, Chiang N, Kethidi N . Quantitative Analysis of SSEA3+ Cells from Human Umbilical Cord after Magnetic Sorting. Cell Transplant. 2019; 28(7):907-923. PMC: 6719495. DOI: 10.1177/0963689719844260. View

19.

Andrzejewska A, Dabrowska S, Lukomska B, Janowski M . Mesenchymal Stem Cells for Neurological Disorders. Adv Sci (Weinh). 2021; 8(7):2002944. PMC: 8024997. DOI: 10.1002/advs.202002944. View

20.

Wakao S, Kitada M, Dezawa M . The elite and stochastic model for iPS cell generation: multilineage-differentiating stress enduring (Muse) cells are readily reprogrammable into iPS cells. Cytometry A. 2012; 83(1):18-26. DOI: 10.1002/cyto.a.22069. View